These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16286385)

  • 1. Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas?
    Patankar TF; Haroon HA; Mills SJ; Balériaux D; Buckley DL; Parker GJ; Jackson A
    AJNR Am J Neuroradiol; 2005; 26(10):2455-65. PubMed ID: 16286385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma?
    Mills SJ; Patankar TA; Haroon HA; Balériaux D; Swindell R; Jackson A
    AJNR Am J Neuroradiol; 2006 Apr; 27(4):853-8. PubMed ID: 16611778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI.
    Jiang JS; Hua Y; Zhou XJ; Shen DD; Shi JL; Ge M; Geng QN; Jia ZZ
    Acad Radiol; 2019 Sep; 26(9):1215-1221. PubMed ID: 30416002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volume-based histogram analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status.
    Hu Y; Zhang N; Yu MH; Zhou XJ; Ge M; Shen DD; Hua Y; Shi JL; Jia ZZ
    Eur J Radiol; 2020 Oct; 131():109247. PubMed ID: 32891974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.
    Nguyen TB; Cron GO; Bezzina K; Perdrizet K; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Thornhill RE; Zanette B; Cameron IG
    AJNR Am J Neuroradiol; 2016 Dec; 37(12):2217-2223. PubMed ID: 27585700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Diagnostic Accuracy of DSC- and Dynamic Contrast-Enhanced MRI in the Preoperative Grading of Astrocytomas.
    Nguyen TB; Cron GO; Perdrizet K; Bezzina K; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Sinclair J; Thornhill RE; Foottit C; Zanette B; Cameron IG
    AJNR Am J Neuroradiol; 2015 Nov; 36(11):2017-22. PubMed ID: 26228886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pixel-by-Pixel Comparison of Volume Transfer Constant and Estimates of Cerebral Blood Volume from Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast-Enhanced MR Imaging in High-Grade Gliomas.
    Alcaide-Leon P; Pareto D; Martinez-Saez E; Auger C; Bharatha A; Rovira A
    AJNR Am J Neuroradiol; 2015 May; 36(5):871-6. PubMed ID: 25634715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
    Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies.
    Hoxworth JM; Eschbacher JM; Gonzales AC; Singleton KW; Leon GD; Smith KA; Stokes AM; Zhou Y; Mazza GL; Porter AB; Mrugala MM; Zimmerman RS; Bendok BR; Patra DP; Krishna C; Boxerman JL; Baxter LC; Swanson KR; Quarles CC; Schmainda KM; Hu LS
    AJNR Am J Neuroradiol; 2020 Mar; 41(3):408-415. PubMed ID: 32165359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of dynamic contrast-enhanced MR imaging using a phase-derived vascular input function in the preoperative grading of gliomas.
    Nguyen TB; Cron GO; Mercier JF; Foottit C; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Caudrelier JM; Sinclair J; Hogan MJ; Thornhill RE; Cameron IG
    AJNR Am J Neuroradiol; 2012 Sep; 33(8):1539-45. PubMed ID: 22442046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Different Post-Processing Algorithms for Dynamic Susceptibility Contrast Perfusion Imaging of Cerebral Gliomas.
    Kudo K; Uwano I; Hirai T; Murakami R; Nakamura H; Fujima N; Yamashita F; Goodwin J; Higuchi S; Sasaki M
    Magn Reson Med Sci; 2017 Apr; 16(2):129-136. PubMed ID: 27646457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assessment of immature microvascular density in brain gliomas with dynamic contrast-enhanced magnetic resonance imaging.
    Jia ZZ; Gu HM; Zhou XJ; Shi JL; Li MD; Zhou GF; Wu XH
    Eur J Radiol; 2015 Sep; 84(9):1805-9. PubMed ID: 26066470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
    Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
    J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High- and low-grade glioma differentiation: the role of percentage signal recovery evaluation in MR dynamic susceptibility contrast imaging.
    Aprile I; Giovannelli G; Fiaschini P; Muti M; Kouleridou A; Caputo N
    Radiol Med; 2015 Oct; 120(10):967-74. PubMed ID: 25762408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
    Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
    J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas.
    Arevalo-Perez J; Peck KK; Young RJ; Holodny AI; Karimi S; Lyo JK
    J Neuroimaging; 2015; 25(5):792-8. PubMed ID: 25867683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular permeability of brain astrocytoma with contrast-enhanced magnetic resonance imaging: correlation analysis with histopathologic grade.
    Jia ZZ; Geng DY; Liu Y; Chen XR; Zhang J
    Chin Med J (Engl); 2013; 126(10):1953-6. PubMed ID: 23673117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma assessment using quantitative blood volume maps generated by T1-weighted dynamic contrast-enhanced magnetic resonance imaging: a receiver operating characteristic study.
    Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
    Acta Radiol; 2006 Apr; 47(3):303-10. PubMed ID: 16613313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.